Trial Profile
Phase II study to determine the treatment duration of KP 1461 required to achieve a clinically meaningful decrease in the viral load in patients with HIV-1 infections
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2011
Price :
$35
*
At a glance
- Drugs KP 1461 (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 20 Jan 2011 New trial record